Group 1 - The total dividend amount of public funds in 2023 has reached 88.9 billion yuan, which is 1.4 times that of the same period last year, marking a three-year high with over 2,500 distributions [1] - Equity funds are increasingly distributing dividends, with ETFs being prominent in the distribution rankings, such as Huaxia CSI 300 ETF with 2.683 billion yuan and Jiashi CSI 300 ETF with 2.435 billion yuan [1] - Several ETFs have also exceeded 1 billion yuan in dividend distributions this year, including E Fund CSI 300 ETF and Southern CSI 500 ETF [1] Group 2 - Penghua Fund has appointed Italian firm Eurizon Capital as an overseas investment advisor for its global high-yield bond fund and US real estate fund, enhancing service for investors [2] - Eurizon Capital, a shareholder of Penghua Fund, had an asset management scale of 390.5 billion euros as of September last year, operating in 25 countries [2] - The trend of QDII funds hiring experienced overseas advisors is growing, with many having over 15 years of industry experience [2] Group 3 - Dongfanghong Asset Management announced the early closure of its core value mixed fund, which is the first floating fee rate fund in the market, with a planned fundraising cap of 2 billion yuan [3][4] - The fund was subscribed with 10 million yuan of the company's own capital [3] Group 4 - Several public funds, including Fuguo Fund and Guotai Fund, have warned investors about risks associated with the recent volatility in the information technology innovation theme ETFs, which have seen a significant increase in scale [5] - As of June 3, the total scale of seven innovation theme ETFs reached 2.544 billion yuan, up over 110% from 1.188 billion yuan on May 23 [5] Group 5 - The Hong Kong innovative drug sector has gained significant attention, with the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index rising over 51% year-to-date [6] - Multiple innovative drug and healthcare ETFs have also seen year-to-date increases exceeding 40%, outperforming gold stock ETFs which rose 36% [7] Group 6 - Investment opportunities in the medical AI sector are concentrated in three main areas: AI drug development, AI in medical diagnostics and treatment, and the production and application of medical data [8] - The application of AI in drug development is expected to enhance efficiency, with several AI-selected drugs entering clinical validation [8] Group 7 - On June 5, the market experienced a rebound, with the Shanghai Composite Index rising 0.23% and the Shenzhen Component Index increasing by 0.58% [9] - The total trading volume in the Shanghai and Shenzhen markets reached 1.29 trillion yuan, an increase of 137.4 billion yuan from the previous trading day [9] - The information technology sector led the gains, with the information technology ETF rising by 3.98% [9]

天赐良基日报第659期 一、今日基金新闻速览 1、年内基金分红总额创近三年同期新高 3、首只新型浮动费率基金提前结募 6月4日晚间，东方红资管发布公告，决定将东方红核心价值混合的募集期截止日提前至6月4日，自6月5日（含）起不再接受认购申请。据了解，该基金为全 市场首只结募的新型浮动费率基金，原定计划募集上限为20亿元。 二、知名基金经理最新动态 1、毛丁丁：医疗AI赛道投资机会集中在三大方向 谈及医疗AI赛道的投资机会，创金合信基金经理毛丁丁近日接受采访时表示，主要集中在三大方向。第一，AI制药。国内外已有多款通过人工智能技术筛 选并推进的药物进入了临床验证阶段，商业模式验证在即。第二，AI医疗。除了关注诊疗环节的AI辅助导诊、问诊、诊断等环节以及预后的辅助健康管理 等环节外，也应积极关注与人工智能结合应用的其他新兴治疗技术。第三，数据生产及应用。能够充分获取并利用高质量诊疗数据的公司具有领先优势，比 如基因测序等体外诊断服务提供商、大型医疗集团等。 三、今日ETF行情点评 1、ETF行情复盘 公募基金的分红热情持续高涨。数据显示，基金今年以来累计分红金额达889亿元，是去年同期的1.4倍，创出近三年的同期 ...

Core Viewpoint - Public funds are actively hiring foreign investment advisors to enhance investment management for QDII funds, driven by the growing demand for diversified asset allocation as residents' wealth continues to increase [1] Group 1: Hiring Foreign Advisors - Penghua Fund announced the hiring of Italy's Eurizon Capital Asset Management as a foreign investment advisor for its global high-yield bond fund and US real estate fund, with Eurizon managing €390.5 billion as of last September [2] - Other public funds are also bringing in foreign advisors, with many having over 15 years of experience in the securities industry, aligning well with the investment directions of the respective QDII funds [2][3] - Notable foreign advisors include Steven Angeli from Wellington Management with over 30 years of experience, and Cai Defeng and Yang Bo from Amundi Asset Management, both with over 16 years of experience [3] Group 2: Expanding Investment Directions - The hiring of foreign advisors reflects support from foreign shareholders and the sharing of investment expertise, which is crucial for navigating complex overseas markets [4] - Public funds are increasingly focusing on global asset allocation capabilities, with a rich lineup of QDII funds covering various international markets, including the US, France, Japan, and more [4] - The popularity of certain QDII funds is evident, as seen with the招商利安新兴亚洲精选ETF reaching its fundraising cap of 1 billion yuan in just one day [4] Group 3: New Fund Offerings - The mutual recognition fund shelf has seen new additions this year, with Morgan Asset Management reporting three new mutual recognition fund products [5] - Multi-asset allocation capabilities are gaining importance, with FOF (Fund of Funds) becoming a key vehicle for diversification, emphasizing the need for familiarity with different asset classes [6]